Literature DB >> 2309582

Production of both interleukin-1 alpha and beta by newborn mouse calvarial cultures.

J A Lorenzo1, S L Sousa, S E Van den Brink-Webb, J H Korn.   

Abstract

The conditioned medium (CM) from 4-6 day newborn mouse calvarial cultures was found to contain thymocyte comitogen proliferation activity. This activity was blocked by an antiserum to murine interleukin-1 alpha (IL-1 alpha) but not by an antiserum to murine interleukin-1 beta. The release of thymocyte comitogen proliferation activity from the cultures did not appear dependent on endotoxin and was not associated with detectable interleukin-2 activity in the CM. Activity in the CM eluted from a gel filtration column with a peak Mr of 16-18 kD (the Mr of mature murine IL-1 alpha and beta is 17 kD). Western immunoblots of 100-fold concentrated CM demonstrated only a single 33 kD band with an antiserum to murine IL-1 beta and no bands with an antiserum to murine IL-1 alpha. However, this assay was relatively insensitive (limit of detection 1-10 ng compared with 1-10 pg for the thymocyte comitogen proliferation assay). Immunoprecipitation of [35S]methionine-labeled CM with three different anti-IL-1 alpha antisera, a more sensitive assay, demonstrated 15-17 kD bands in all cases. These results demonstrate that 4-6 day newborn mouse calvarial cultures spontaneously release 17 kD IL-1 alpha and 33 kD IL-1 beta into their conditioned medium. It appears that although 17 kD IL-1 alpha is the major bioactive form in the CM, 33 kD IL-1 beta is present in greater amounts. These results also suggest that local production of IL-1 can regulate bone cell function and may play a role in bone growth and remodeling.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2309582     DOI: 10.1002/jbmr.5650050112

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  6 in total

Review 1.  Osteoimmunology: interactions of the bone and immune system.

Authors:  Joseph Lorenzo; Mark Horowitz; Yongwon Choi
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

2.  Central IL-1 receptor signaling regulates bone growth and mass.

Authors:  Alon Bajayo; Inbal Goshen; Sharon Feldman; Valer Csernus; Kerstin Iverfeldt; Esther Shohami; Raz Yirmiya; Itai Bab
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-26       Impact factor: 11.205

3.  Expression of inflammatory cytokine genes in vivo by human alveolar bone-derived polymorphonuclear leukocytes isolated from chronically inflamed sites of bone resorption.

Authors:  O Takeichi; I Saito; T Tsurumachi; I Moro; T Saito
Journal:  Calcif Tissue Int       Date:  1996-04       Impact factor: 4.333

4.  Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae.

Authors:  H Kawaguchi; C C Pilbeam; S J Vargas; E E Morse; J A Lorenzo; L G Raisz
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

5.  Interactions of tumor necrosis factor with local and systemic factors in fetal rat limb bones.

Authors:  G Shankar; P H Stern
Journal:  Calcif Tissue Int       Date:  1992-11       Impact factor: 4.333

6.  The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitro.

Authors:  A M Flanagan; M D Stow; N Kendall; W Brace
Journal:  Int J Exp Pathol       Date:  1995-02       Impact factor: 1.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.